167 related articles for article (PubMed ID: 16010410)
1. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells.
Cramer SD; Peehl DM; Edgar MG; Wong ST; Deftos LJ; Feldman D
Prostate; 1996 Jul; 29(1):20-9. PubMed ID: 8685051
[TBL] [Abstract][Full Text] [Related]
3. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
Henttu P; Vihko P
Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Okamoto M; Lee C; Oyasu R
Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
[TBL] [Abstract][Full Text] [Related]
5. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
Lin MF; DaVolio J; Garcia-Arenas R
Cancer Res; 1992 Sep; 52(17):4600-7. PubMed ID: 1380886
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Mazzucchelli L; Loetscher P; Kappeler A; Uguccioni M; Baggiolini M; Laissue JA; Mueller C
Am J Pathol; 1996 Aug; 149(2):501-9. PubMed ID: 8701989
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
[TBL] [Abstract][Full Text] [Related]
8. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
Walensky LD; Coffey DS; Chen TH; Wu TC; Pasternack GR
Cancer Res; 1993 Oct; 53(19):4720-6. PubMed ID: 7691403
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
Pflug BR; Onoda M; Lynch JH; Djakiew D
Cancer Res; 1992 Oct; 52(19):5403-6. PubMed ID: 1382843
[TBL] [Abstract][Full Text] [Related]
10. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
Landry F; Chapdelaine A; Bégin LR; Chevalier S
J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
[TBL] [Abstract][Full Text] [Related]
12. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein.
Djakiew D; Pflug BR; Delsite R; Onoda M; Lynch JH; Arand G; Thompson EW
Cancer Res; 1993 Mar; 53(6):1416-20. PubMed ID: 8443820
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor gene expression in human prostate carcinoma cell lines.
Tilley WD; Wilson CM; Marcelli M; McPhaul MJ
Cancer Res; 1990 Sep; 50(17):5382-6. PubMed ID: 2386943
[TBL] [Abstract][Full Text] [Related]
14. Regulation of prostatic growth and function by peptide growth factors.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
Pavone-Macaluso M; Carruba G; Castagnetta L
Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
[TBL] [Abstract][Full Text] [Related]
17. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
Bonkhoff H; Remberger K
Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
Rajan R; Vanderslice R; Kapur S; Lynch J; Thompson R; Djakiew D
Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275
[TBL] [Abstract][Full Text] [Related]
19. Changes in keratin expression during the development of benign prostatic hyperplasia.
Xue Y; Smedts F; Umbas R; Aalders TW; Debruyne FM; de la Rosette JJ; Schalken JA
Eur Urol; 1997; 32(3):332-8. PubMed ID: 9358223
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
Schleicher RL; Hunter SB; Zhang M; Zheng M; Tan W; Bandea CI; Fallon MT; Bostwick DG; Varma VA
Cancer Res; 1997 Aug; 57(16):3532-6. PubMed ID: 9270025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
